Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AZN compared with TMO: revenue, margins and what each company keeps, and the suppliers and customers both name
AZN
Astrazeneca PLC
Change
Mkt cap
Revenue
Revenue
TMO
Thermo Fisher Scientific Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AZN
Astrazeneca PLC
vs
TMO
Thermo Fisher Scientific Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
AZN
No earnings history for AZN.
TMO
2 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±4.9%
▲
+0.97%
×0.20
Q2 FY26
±4.9%
▲
+8.71%
×1.78
Q1 FY26
±4.1%
▼
−9.20%
×2.24
Jan 29 '26
±3.7%
▼
−2.61%
×0.70
= implied
AZN realized, solid
TMO realized, hatched
One scale, both sides: full bar = 10%
× = |realized| ÷ implied
Source: market data
AZN
Astrazeneca PLC
Change
186.61
· pre 185.79
· delayed
Mkt cap
$289.4B
Revenue
—
Revenue
—
TMO
Thermo Fisher Scientific Inc.
Change
682.77
· pre 682.00
· delayed
Pre-market
Nov 3 '26
delayed
Mkt cap
$252.9B
Revenue
$12.1B
Q3 FY26
Revenue
$44.6B
FY25
vs
Compare
Pre-market
Nov 3 '26
delayed
AZN
Astrazeneca PLC
vs
TMO
Thermo Fisher Scientific Inc.
186.61
pre 185.79
delayed
Price
682.77
pre 682.00
delayed
$289.4B
Mkt cap
$252.9B
—
Revenue
$12.1B
Q3 FY26
—
Revenue
$44.6B
FY25
Change
Change
AZN
186.61
vs
TMO
682.77
Pre-market
Nov 3 '26
delayed